Crossmark

Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals

Crossref DOI link: https://doi.org/10.1136/rmdopen-2022-002512

Published Online: 2022-12-19

Published Print: 2022-12

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Ponchel, Frederique https://orcid.org/0000-0002-3969-7701
Duquenne, Laurence https://orcid.org/0000-0001-7631-0986
Xie, Xuanxiao

Corscadden, Diane

Shuweihdi, Farag

Mankia, K https://orcid.org/0000-0002-7945-6582
Trouw, L A

Emery, Paul https://orcid.org/0000-0002-7429-8482
Funding

Funding for this research was provided by:

China Research Council (No. 201708330243)

European Research Council (no. 724517)
License Information

License valid from 2022-12-19